Report Detail
Global Drug Repurposing Market Research Report 2019
- RnM3086809 |
- 09 March, 2019 |
- Global |
- 92 Pages |
- QYResearch |
- Pharma & Healthcare
Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositioned. National Institute of Health (NIH), U.S. Department of Health defines drug repurposing as discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside. Drug repurposing opens up various opportunities to answer current unmet medical needs to come up with cost-effective solutions to expensive drug development process. Repurposing or re-profiling of drugs which are suspended due to lack of efficacy or specificity can be a good start over for further development for new indication. Finding new indications for already studied drugs can benefit patients by getting quick access to new treatment choices and also to developer by saving time and money while maintaining its original IP protection. For many expensive indications such as cancer, scrutinizing for anti-cancer activity among dozens of off-patent drugs that have already established their safety is a powerful method opted by majority of the big pharma companies. However, repurposing is not a new strategy and there are bunch of drugs which are repositioned or repurposed, some of them are Raloxifene (approved for treatment of osteoporosis in 2007, originally indicated for breast cancer treatment), Thalidomide (repositioned for use in treatment of leprosy and multiple myeloma in 2006), Rapamycin (repurposed in 1999 for prevention of organ transplant rejection), Sildenafil (originally approved for erectile dysfunction and recently got approved for treatment of angina) and many others.
Requirement of low investment of time and money in the drug development is the prime advantage of drug repurposing and majority of the drugs in pipeline of major pharmaceutical companies are thus adopt this method. Some of the factors accelerating the drug repurposing activities include sunk research cost, ready availably of bioavailability, pharmacology, toxicity profile & pharmacokinetics data, well established manufacturing protocol etc.; which are expected to drive the global drug repurposing market. There are thousands of failed molecules shelved into the drug libraries, which hold vast potential to reposition. Whereas, limited access chemical structure data of drug molecules, lack of funding etc. are some of the factors limiting the growth of global drug repurposing market.
The global Drug Repurposing market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Drug Repurposing volume and value at global level, regional level and company level. From a global perspective, this report represents overall Drug Repurposing market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Astellas Pharma
Biovista
Novartis
AbbVie
Pfizer
Allergan
NuMedii
...
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Oncology
CNS Diseases
Neurodegenerative Diseases
Others
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
Table of Contents
Executive Summary
1 Drug Repurposing Market Overview
- 1.1 Product Overview and Scope of Drug Repurposing
- 1.2 Drug Repurposing Segment by Type
- 1.2.1 Global Drug Repurposing Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Oncology
- 1.2.3 CNS Diseases
- 1.2.4 Neurodegenerative Diseases
- 1.2.5 Others
- 1.3 Drug Repurposing Segment by Application
- 1.3.1 Drug Repurposing Consumption Comparison by Application (2014-2025)
- 1.3.2 Hospitals
- 1.3.3 Ambulatory Surgical Centers
- 1.3.4 Others
- 1.4 Global Drug Repurposing Market by Region
- 1.4.1 Global Drug Repurposing Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Drug Repurposing Market Size
- 1.5.1 Global Drug Repurposing Revenue (2014-2025)
- 1.5.2 Global Drug Repurposing Production (2014-2025)
2 Global Drug Repurposing Market Competition by Manufacturers
- 2.1 Global Drug Repurposing Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Drug Repurposing Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Drug Repurposing Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Drug Repurposing Production Sites, Area Served, Product Types
- 2.5 Drug Repurposing Market Competitive Situation and Trends
- 2.5.1 Drug Repurposing Market Concentration Rate
- 2.5.2 Drug Repurposing Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Drug Repurposing Production Market Share by Regions
- 3.1 Global Drug Repurposing Production Market Share by Regions
- 3.2 Global Drug Repurposing Revenue Market Share by Regions (2014-2019)
- 3.3 Global Drug Repurposing Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Drug Repurposing Production
- 3.4.1 North America Drug Repurposing Production Growth Rate (2014-2019)
- 3.4.2 North America Drug Repurposing Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Drug Repurposing Production
- 3.5.1 Europe Drug Repurposing Production Growth Rate (2014-2019)
- 3.5.2 Europe Drug Repurposing Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Drug Repurposing Production (2014-2019)
- 3.6.1 China Drug Repurposing Production Growth Rate (2014-2019)
- 3.6.2 China Drug Repurposing Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Drug Repurposing Production (2014-2019)
- 3.7.1 Japan Drug Repurposing Production Growth Rate (2014-2019)
- 3.7.2 Japan Drug Repurposing Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Drug Repurposing Consumption by Regions
- 4.1 Global Drug Repurposing Consumption by Regions
- 4.2 North America Drug Repurposing Consumption (2014-2019)
- 4.3 Europe Drug Repurposing Consumption (2014-2019)
- 4.4 China Drug Repurposing Consumption (2014-2019)
- 4.5 Japan Drug Repurposing Consumption (2014-2019)
5 Global Drug Repurposing Production, Revenue, Price Trend by Type
- 5.1 Global Drug Repurposing Production Market Share by Type (2014-2019)
- 5.2 Global Drug Repurposing Revenue Market Share by Type (2014-2019)
- 5.3 Global Drug Repurposing Price by Type (2014-2019)
- 5.4 Global Drug Repurposing Production Growth by Type (2014-2019)
6 Global Drug Repurposing Market Analysis by Applications
- 6.1 Global Drug Repurposing Consumption Market Share by Application (2014-2019)
- 6.2 Global Drug Repurposing Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Drug Repurposing Business
- 7.1 Astellas Pharma
- 7.1.1 Astellas Pharma Drug Repurposing Production Sites and Area Served
- 7.1.2 Drug Repurposing Product Introduction, Application and Specification
- 7.1.3 Astellas Pharma Drug Repurposing Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 Biovista
- 7.2.1 Biovista Drug Repurposing Production Sites and Area Served
- 7.2.2 Drug Repurposing Product Introduction, Application and Specification
- 7.2.3 Biovista Drug Repurposing Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Novartis
- 7.3.1 Novartis Drug Repurposing Production Sites and Area Served
- 7.3.2 Drug Repurposing Product Introduction, Application and Specification
- 7.3.3 Novartis Drug Repurposing Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 AbbVie
- 7.4.1 AbbVie Drug Repurposing Production Sites and Area Served
- 7.4.2 Drug Repurposing Product Introduction, Application and Specification
- 7.4.3 AbbVie Drug Repurposing Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Pfizer
- 7.5.1 Pfizer Drug Repurposing Production Sites and Area Served
- 7.5.2 Drug Repurposing Product Introduction, Application and Specification
- 7.5.3 Pfizer Drug Repurposing Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 Allergan
- 7.6.1 Allergan Drug Repurposing Production Sites and Area Served
- 7.6.2 Drug Repurposing Product Introduction, Application and Specification
- 7.6.3 Allergan Drug Repurposing Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 NuMedii
- 7.7.1 NuMedii Drug Repurposing Production Sites and Area Served
- 7.7.2 Drug Repurposing Product Introduction, Application and Specification
- 7.7.3 NuMedii Drug Repurposing Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
8 Drug Repurposing Manufacturing Cost Analysis
- 8.1 Drug Repurposing Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Drug Repurposing
- 8.4 Drug Repurposing Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Drug Repurposing Distributors List
- 9.3 Drug Repurposing Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Drug Repurposing Market Forecast
- 11.1 Global Drug Repurposing Production, Revenue Forecast
- 11.1.1 Global Drug Repurposing Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Drug Repurposing Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Drug Repurposing Price and Trend Forecast (2019-2025)
- 11.2 Global Drug Repurposing Production Forecast by Regions (2019-2025)
- 11.2.1 North America Drug Repurposing Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Drug Repurposing Production, Revenue Forecast (2019-2025)
- 11.2.3 China Drug Repurposing Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Drug Repurposing Production, Revenue Forecast (2019-2025)
- 11.3 Global Drug Repurposing Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Drug Repurposing Consumption Forecast (2019-2025)
- 11.3.2 Europe Drug Repurposing Consumption Forecast (2019-2025)
- 11.3.3 China Drug Repurposing Consumption Forecast (2019-2025)
- 11.3.4 Japan Drug Repurposing Consumption Forecast (2019-2025)
- 11.4 Global Drug Repurposing Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Drug Repurposing Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Drug Repurposing. Industry analysis & Market Report on Drug Repurposing is a syndicated market report, published as Global Drug Repurposing Market Research Report 2019. It is complete Research Study and Industry Analysis of Drug Repurposing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
